XML 15 R2.htm IDEA: XBRL DOCUMENT v3.25.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2025
Dec. 31, 2024
Assets    
Fixed maturity securities available-for-sale, at fair value (amortized cost of $5,992,370 and $5,876,502; allowance for credit losses of $273 and $0) $ 5,815,337 $ 5,624,773
Short-term investments, at fair value 3,696 3,367
Total investments 5,819,033 5,628,140
Cash and cash equivalents 635,269 599,432
Accrued investment income 49,653 49,595
Deferred acquisition costs 23,322 23,771
Premiums receivable 46,451 53,031
Other assets 103,352 102,549
Deferred tax asset 44,440 65,013
Total assets 6,721,520 6,521,531
Liabilities:    
Loss reserves 542,528 524,715
Unearned premiums 107,519 114,680
Other liabilities 208,667 142,990
Long-term borrowings 743,399 743,050
Total liabilities 1,602,113 1,525,435
Equity:    
Common stock ($0.01 par value; 600,000 shares authorized; 150,765 shares issued and outstanding as of March 31, 2025, and 152,318 shares issued and outstanding as of December 31, 2024) 1,508 1,523
Additional paid-in capital 2,007,776 2,076,788
Accumulated other comprehensive income (152,482) (207,455)
Retained earnings 3,262,605 3,125,240
Total equity 5,119,407 4,996,096
Total liabilities and equity $ 6,721,520 $ 6,521,531